Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer

Endocrine-Related Cancer

Volumn 16, Issue 4, 2009, Pages 1291-1298

  Machens, Andreas ^a   Hoffmann, Florian ^a   Sekulla, Carsten ^a   Dralle, Henning ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; PENTAGASTRIN;

ARTICLE; C CELL HYPERPLASIA; CALCITONIN BLOOD LEVEL; CELL HYPERPLASIA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GOITER; HISTOPATHOLOGY; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDULLARY THYROID CANCER; PREDICTION; PREOPERATIVE PERIOD; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SINGLE DRUG DOSE; THYROID CANCER; THYROIDITIS;

CALCITONIN; CARCINOMA, MEDULLARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; LYMPH NODE EXCISION; MALE; MIDDLE AGED; PENTAGASTRIN; RETROSPECTIVE STUDIES; SEX FACTORS; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 72549112513     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-09-0136     Document Type: Article

References (24)

1. Bieglmayer C, Vierhapper H, Dudczak R & Niederle B 2007 Measurement of calcitonin by immunoassay analyzers. Clinical Chemistry and Laboratory Medicine 45 662-666.
2. Borget I, de Pouvourville G & Schlumberger M 2007 Editorial: calcitonin determination in patients with nodular thyroid disease. Journal of Clinical Endocrinology and Metabolism 92 425-427. (Pubitemid 46255274)
3. Cheung K, Roman SA, Wang TS, Walker HD & Sosa JA 2008 Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis. Journal of Clinical Endocrinology and Metabolism 93 2173-2180. (Pubitemid 351831532)
4. Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M et al. 2007 Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. Journal of Clinical Endocrinology and Metabolism 92 450-455. (Pubitemid 46255279)
5. Dralle H 2002 Lymph node dissection and medullary thyroid carcinoma. British Journal of Surgery 89 1073-1075. (Pubitemid 34989210)
6. Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A et al. 2004 Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. Journal of Clinical Endocrinology and Metabolism 89 163-168. (Pubitemid 38183876)
7. Guyetant S, Wion-Barbot N, Rousselet MC, Franc B, Bigorgne JC & Saint-Andre JP 1994 C-cell hyperplasia associated with chronic lymphocytic thyroiditis: a retrospective quantitative study of 112 cases. Human Pathology 25 514-521. (Pubitemid 24173869)
8. Hahm JR, Lee MS, Min YK, Lee MK, Kim KW, Nam SJ, Yang JH & Chung JH 2001 Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Thyroid 11 73-80.
9. Heath H & Sizemore GW 1977 Plasma calcitonin in normal man. Differences between men and women. Journal of Clinical Investigation 60 1135-1140.
10. Hinze R, Holzhausen HJ, Gimm O, Dralle H & Rath FW 1998 Primary hereditary medullary thyroid carcinoma - C-cell morphology and correlation with preoperative calcitonin levels. Virchows Archiv 433 203-208. (Pubitemid 28448674)
11. Iacobone M, Niccoli-Sire P, Sebag F, De Micco C & Henry JF 2002 Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels World Journal of Surgery 26 886-890.
12. Karges W, Dralle H, Raue F, Mann K, Reiners C, Grussendorf M, Hüfner M, Niederle B, Brabant G & German Society for Endocrinology (DGE) - Thyroid Section 2004 Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Experimental and Clinical Endocrinology & Diabetes 112 52-58.
13. Machens A, Gimm O, Ukkat J, Hinze R, Schneyer U & Dralle H 2000a Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis. Cancer 88 1909-1915. (Pubitemid 30213002)
14. Machens A, Haedecke J, Holzhausen HJ, Thomusch O, Schneyer U & Dralle H 2000b Differential diagnosis of calcitonin-secreting neuroendocrine carcinoma of the foregut by pentagastrin stimulation. Langenbeck's Archives of Surgery 385 398-401. (Pubitemid 30818695)
15. Machens A, Niccoli-Sire P, Hoegel J, Frank-Raue K, van Vroonhoven TJ, Röher HD, Wahl RA, Lamesch P, Raue F, Conte-Devolx B et al. 2003 Early malignant progression of hereditary medullary thyroid cancer. New England Journal of Medicine 349 1517-1525. (Pubitemid 37255037)
16. Machens A, Schneyer U, Holzhausen HJ & Dralle H 2005 Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. Journal of Clinical Endocrinology and Metabolism 90 2029-2034. (Pubitemid 40586235)
17. Machens A, Hofmann C, Hauptmann S & Dralle H 2007 Locoregional recurrence and death from medullary thyroid carcinoma in a contemporaneous series: 5-year results. European Journal of Endocrinology 157 85-93. (Pubitemid 47162570)
18. Oskam IM, Hoebers F, Balm AJM, van Coevorden F, Bais EM, Hart AM & van den Brekel MW 2008 Neck management in medullary thyroid carcinoma. European Journal of Surgical Oncology 34 71-76. (Pubitemid 350296762)
19. Pantazi H & Papapetrou PD 1998 Calcitonin levels are similar in goitrous euthyroid patients with or without thyroid antibodies, as well as in hypothyroid patients. European Journal of Endocrinology 138 530-535. (Pubitemid 28238188)
20. Rink T, Truong PN, Schroth HJ, Diener J, Zimny M & Grünwald F 2009 Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease. Thyroid 19 327-332.
21. Scheuba C, Kaserer K, Moritz A, Drosten R, Vierhapper H, Bieglmayer C, Haas OA & Niederle B 2009 Sporadic hypercalcitoninemia. Clinical and therapeutic consequences. Endocrine-Related Cancer 16 243-253.
22. Scollo C, Baudin E, Travagli JP, Caillou B, Bellon N, Leboulleux S & Schlumberger M 2003 Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. Journal of Clinical Endocrinology and Metabolism 88 2070-2075. (Pubitemid 36549878)
23. Vierhapper H, Niederle B, Bieglmayer C, Kaserer K & Baumgartner-Parzer S 2005 Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid 15 1267-1272. (Pubitemid 41821761)
24. Weinhaeusel A, Scheuba C, Lauss M, Kriegner A, Kaserer K, Vierlinger K, Haas OA & Niederle B 2008 The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma. Thyroid 18 1269-1276.